
----- Abstraction Phase -----
[2026-01-14 16:17:31]
ğŸ§± ABSTRACTION â€” The features abstracted by the text are:
* [1] The category is "Allergies" for the finding "No known drug allergies" and the explanation is "The patient had no known allergies.".
* [2] The category is "Social & Community Context" for the finding "Occupation" and the explanation is "Retired plumber.".
* [3] The category is "Social & Community Context" for the finding "Asbestos exposure" and the explanation is "Worked in a shipyard with asbestos exposure.".
* [4] The category is "Social & Community Context" for the finding "Tobacco use" and the explanation is "Smoked 3 packs per day for 50 years, quit 14 years ago.".
* [5] The category is "Social & Community Context" for the finding "Alcohol use" and the explanation is "Occasional alcohol consumption.".
* [6] The category is "Social & Community Context" for the finding "Illicit drug use" and the explanation is "Denies illicit drug use.".
* [7] The category is "Family History" for the finding "Maternal death" and the explanation is "Mother died at age 49 of unknown causes.".
* [8] The category is "Family History" for the finding "Paternal cancer" and the explanation is "Father died of colon cancer.".
* [9] The category is "Family History" for the finding "Sibling disease" and the explanation is "Brother had heart disease and asbestosis.".
* [10] The category is "Past Medical History" for the finding "Diabetes mellitus" and the explanation is "Patient has diabetes mellitus.".
* [11] The category is "Past Medical History" for the finding "Coronary artery disease" and the explanation is "Coronary artery disease treated with a stent 10 years earlier.".
* [12] The category is "Past Medical History" for the finding "Complete heart block" and the explanation is "Diagnosed 6 years ago, treated with pacemaker insertion.".
* [13] The category is "Past Medical History" for the finding "Hypertension" and the explanation is "Patient has a history of hypertension.".
* [14] The category is "Past Medical History" for the finding "Hyperlipidemia" and the explanation is "Patient has hyperlipidemia.".
* [15] The category is "Past Medical History" for the finding "Cerebrovascular disease" and the explanation is "Patient has cerebrovascular disease.".
* [16] The category is "Past Medical History" for the finding "Osteoarthritis" and the explanation is "Patient has osteoarthritis.".
* [17] The category is "Past Medical History" for the finding "Hearing impairment" and the explanation is "Patient has hearing impairment.".
* [18] The category is "Past Medical History" for the finding "Vertigo" and the explanation is "Patient has vertigo.".
* [19] The category is "Past Medical History" for the finding "Cataracts" and the explanation is "Patient has cataracts.".
* [20] The category is "Past Medical History" for the finding "Transurethral prostatectomy" and the explanation is "Patient underwent transurethral prostatectomy in the past.".
* [21] The category is "Past Medical History" for the finding "Progressive dyspnea" and the explanation is "Dyspnea began 6 months prior to admission and progressively worsened.".
* [22] The category is "Past Medical History" for the finding "Weight loss" and the explanation is "Lost approximately 2.3 kg over the prior 2 months.".
* [23] The category is "Past Medical History" for the finding "Chronic dry cough" and the explanation is "Dry cough unchanged throughout the course.".
* [24] The category is "Current Medications" for the finding "Metformin" and the explanation is "Current medication.".
* [25] The category is "Current Medications" for the finding "Rosiglitazone" and the explanation is "Current medication.".
* [26] The category is "Current Medications" for the finding "Acetylsalicylic acid (low dose)" and the explanation is "Current medication.".
* [27] The category is "Current Medications" for the finding "Captopril" and the explanation is "Current medication.".
* [28] The category is "Current Medications" for the finding "Metoprolol" and the explanation is "Current medication.".
* [29] The category is "Current Medications" for the finding "Atorvastatin" and the explanation is "Current medication.".
* [30] The category is "Current Medications" for the finding "Furosemide" and the explanation is "Current medication; additional IV doses administered during admission.".
* [31] The category is "Current Medications" for the finding "Tolazamide" and the explanation is "Current medication.".
* [32] The category is "Current Medications" for the finding "Nifedipine" and the explanation is "Current medication.".
* [33] The category is "Current Medications" for the finding "Cimetidine" and the explanation is "Current medication.".
* [34] The category is "Current Medications" for the finding "Esomeprazole" and the explanation is "Started during admission.".
* [35] The category is "Current Medications" for the finding "Insulin (sliding scale)" and the explanation is "Started during admission for hyperglycemia.".
* [36] The category is "Current Medications" for the finding "Heparin" and the explanation is "Started during admission.".
* [37] The category is "Current Medications" for the finding "Sodium polystyrene sulfonate" and the explanation is "Administered during admission.".
* [38] The category is "Current Medications" for the finding "Ceftriaxone" and the explanation is "Administered during admission.".
* [39] The category is "Current Medications" for the finding "Azithromycin" and the explanation is "Administered during admission.".
* [40] The category is "Current Medications" for the finding "Levofloxacin" and the explanation is "Administered during admission.".
* [41] The category is "Current Medications" for the finding "Prednisone" and the explanation is "Administered during admission.".
* [42] The category is "Current Medications" for the finding "Morphine" and the explanation is "Administered during admission.".
* [43] The category is "Current Medications" for the finding "Bronchodilators" and the explanation is "Administered during admission.".
* [44] The category is "Current Medications" for the finding "Stressâ€‘dose corticosteroids" and the explanation is "Administered during admission.".
* [45] The category is "Physical Examination" for the finding "Temperature" and the explanation is "36.1Â°C on arrival to the emergency department.".
* [46] The category is "Physical Examination" for the finding "Blood pressure" and the explanation is "105/43 mmâ€¯Hg on arrival to the emergency department.".
* [47] The category is "Physical Examination" for the finding "Pulse" and the explanation is "81 beats per minute on arrival to the emergency department.".
* [48] The category is "Physical Examination" for the finding "Respiratory rate" and the explanation is "28 breaths per minute on arrival to the emergency department.".
* [49] The category is "Physical Examination" for the finding "Oxygen saturation" and the explanation is "78â€¯% on room air, 91â€¯% with 6â€¯L/min nasal cannula, 100â€¯% with nonâ€‘rebreather mask.".
* [50] The category is "Physical Examination" for the finding "Jugular venous pressure" and the explanation is "Visible at 14â€¯cm above the right atrium.".
* [51] The category is "Physical Examination" for the finding "Lung auscultation" and the explanation is "Crackles extending halfway up the lungs bilaterally, occasional expiratory wheezes.".
* [52] The category is "Physical Examination" for the finding "Other systems" and the explanation is "Examination otherwise normal.".
* [53] The category is "Investigations" for the finding "Electrocardiogram (EMS)" and the explanation is "Paced rhythm, rate 60â€¯bpm, no ectopy.".
* [54] The category is "Investigations" for the finding "Electrocardiogram (ED)" and the explanation is "Pacemaker rate 88â€¯bpm.".
* [55] The category is "Investigations" for the finding "Chest radiograph (initial)" and the explanation is "Bilateral coarse reticular opacities, most pronounced at the lung bases.".
* [56] The category is "Investigations" for the finding "Chest radiograph (subsequent)" and the explanation is "Bilateral patchy airâ€‘space opacities, indistinct pulmonary vessels, possible small pleural effusions, dualâ€‘lead pacemaker on left chest wall.".
* [57] The category is "Investigations" for the finding "Chest radiograph (day 2)" and the explanation is "Decreased airâ€‘space opacities, calcified pleural plaques on right hemidiaphragm, coarse reticular opacities with increased cystic lucency at both bases.".
* [58] The category is "Investigations" for the finding "CT chest (day 3)" and the explanation is "Calcified pericardium and pleura, mildâ€‘moderate aortic atherosclerosis, dualâ€‘chamber pacemaker leads in innominate vein, right atrial appendage, and right ventricular septum; lymph nodes 1.5â€‘2.3â€¯cm; cystic changes, septal thickening, honeycomb, traction bronchiectasis, diffuse asymmetric groundâ€‘glass opacification.".
* [59] The category is "Investigations" for the finding "Transthoracic echocardiogram (day 3)" and the explanation is "Mild concentric LV hypertrophy, EF 54â€¯%; markedly dilated hypokinetic RV; moderateâ€‘toâ€‘severe tricuspid regurgitation; pulmonary arterial hypertension; systolic and diastolic flattening of interventricular septum consistent with RV volume and pressure overload.".
* [60] The category is "Investigations" for the finding "Cardiac biomarkers" and the explanation is "Serial testing showed no evidence of myocardial infarction.".
* [61] The category is "Current Medications" for the finding "Oxygen therapy" and the explanation is "Supplemental oxygen (15â€¯L/min by nonâ€‘rebreather, later nasal cannula, then bilevel/CPAP, eventually mechanical ventilation).".
* [62] The category is "Current Medications" for the finding "Intravenous furosemide" and the explanation is "Administered during transport and throughout admission as needed for diuresis.".
* [63] The category is "Investigations" for the finding "Laboratory results" and the explanation is "Table 1 referenced but specific values not provided in narrative.".
* [64] The category is "History of Present Illness" for the finding "Onset and progression" and the explanation is "Dyspnea began 6â€¯months prior, initially with exercise tolerance decreasing from three blocks to one flight of stairs; worsened 3â€¯days before admission, limiting walking to twoâ€‘three steps on level ground.".
* [65] The category is "History of Present Illness" for the finding "Associated symptoms" and the explanation is "Somnolence, decreased appetite, reduced urine output, unsteady gait; no fever, chills, night sweats, chest pain, or leg edema.".
* [66] The category is "History of Present Illness" for the finding "Weight loss" and the explanation is "Approximate 2.3â€¯kg loss over prior 2â€¯months.".
* [67] The category is "History of Present Illness" for the finding "Preâ€‘hospital treatment" and the explanation is "Oxygen (15â€¯L/min) and furosemide administered by EMS with improvement.".
* [68] The category is "Investigations" for the finding "Syncopal episode (hospital day 1)" and the explanation is "BP initially 60â€¯mmâ€¯Hg systolic, recovered to 140/68â€¯mmâ€¯Hg after 5â€¯minutes.".
* [69] The category is "Investigations" for the finding "Intermittent desaturation" and the explanation is "Oâ‚‚ saturation 77â€‘85â€¯% while receiving 10â€¯L/min oxygen via nonâ€‘rebreather mask on hospital day 3.".
* [70] The category is "Investigations" for the finding "Respiratory support escalation" and the explanation is "Bilevel and CPAP support attempted; eventual intubation and mechanical ventilation on day 7.".
* [71] The category is "Investigations" for the finding "Outcome" and the explanation is "On hospital day 8, asystolic cardiac arrest occurred; family elected no resuscitation; patient pronounced dead.".
* [72] The category is "Investigations" for the finding "Autopsy" and the explanation is "Performed after death.".

----- Abduction Phase (Unfocused) -----
[2026-01-14 16:19:34]
ğŸ§  ABDUCTION (UNFOCUSED) â€” Diagnostic hypotheses generated:

1. Occupational/interstitial lung disease (asbestosis/idiopathic pulmonary fibrosis)
  Why: Longâ€‘standing asbestos exposure with progressive dyspnea, dry cough, weight loss and radiologic findings of reticular opacities, honeycombing, and pleural plaques suggest a fibrotic interstitial lung process.
  Supporting features:
    - 3. Asbestos exposure â€” Worked in a shipyard with asbestos exposure.
    - 21. Progressive dyspnea â€” Dyspnea began 6â€¯months prior to admission and progressively worsened.
    - 22. Weight loss â€” Lost approximately 2.3â€¯kg over the prior 2â€¯months.
    - 23. Chronic dry cough â€” Dry cough unchanged throughout the course.
    - 55. Chest radiograph (initial) â€” Bilateral coarse reticular opacities, most pronounced at the lung bases.
    - 57. Chest radiograph (day 2) â€” Decreased airâ€‘space opacities, calcified pleural plaques on right hemidiaphragm, coarse reticular opacities with increased cystic lucency at both bases.
    - 58. CT chest (day 3) â€” ... cystic changes, septal thickening, honeycomb changes, traction bronchiectasis, diffuse asymmetric groundâ€‘glass opacification.

2. Pulmonary hypertension secondary to chronic lung disease (Groupâ€¯3 PH)
  Why: Chronic interstitial lung disease with hypoxemia leads to pulmonary vascular remodeling, reflected by rightâ€‘ventricular overload and elevated pulmonary artery pressures.
  Supporting features:
    - 21. Progressive dyspnea â€” Dyspnea began 6â€¯months prior to admission and progressively worsened.
    - 49. Oxygen saturation â€” 78â€¯% on room air, 91â€¯% with 6â€¯L/min nasal cannula, 100â€¯% with nonâ€‘rebreather mask.
    - 58. CT chest (day 3) â€” ... diffuse asymmetric groundâ€‘glass opacification.
    - 59. Transthoracic echocardiogram (day 3) â€” ... markedly dilated hypokinetic RV; moderateâ€‘toâ€‘severe tricuspidâ€‘valve regurgitation; pulmonary arterial hypertension; systolic and diastolic flattening of interventricular septum consistent with RV volume and pressure overload.

3. Rightâ€‘sided heart failure / cor pulmonale
  Why: Elevated jugular venous pressure, dilated hypokinetic right ventricle, tricuspid regurgitation, and systemic hypotension indicate rightâ€‘heart failure secondary to chronic lung disease.
  Supporting features:
    - 50. Jugular venous pressure â€” Visible at 14â€¯cm above the right atrium.
    - 59. Transthoracic echocardiogram (day 3) â€” Markedly dilated hypokinetic RV; moderateâ€‘toâ€‘severe tricuspidâ€‘valve regurgitation; pulmonary arterial hypertension; systolic and diastolic flattening of interventricular septum consistent with RV volume and pressure overload.
    - 46. Blood pressure â€” 105/43 mmâ€¯Hg on arrival to the emergency department.
    - 68. Syncopal episode (hospital day 1) â€” BP initially 60â€¯mmâ€¯Hg; recovered to 140/68â€¯mmâ€¯Hg after 5â€¯minutes.

4. Acute decompensated leftâ€‘sided heart failure (volume overload)
  Why: Bilateral crackles, airâ€‘space opacities, low blood pressure, and rapid response to furosemide are typical of acute pulmonary edema due to leftâ€‘ventricular failure.
  Supporting features:
    - 51. Lung auscultation â€” Crackles extending halfway up the lungs bilaterally, occasional expiratory wheezes.
    - 55. Chest radiograph (initial) â€” Bilateral coarse reticular opacities, most pronounced at the lung bases.
    - 56. Chest radiograph (subsequent) â€” Bilateral patchy airâ€‘space opacities, indistinct pulmonary vessels, possible small pleural effusions.
    - 46. Blood pressure â€” 105/43 mmâ€¯Hg on arrival to the emergency department.
    - 68. Syncopal episode (hospital day 1) â€” BP initially 60â€¯mmâ€¯Hg; recovered to 140/68â€¯mmâ€¯Hg after 5â€¯minutes.
    - 62. Intravenous furosemide â€” Administered during transport and throughout admission as needed for diuresis.

5. Pacemakerâ€‘related cardiac complication (device malfunction or arrhythmia)
  Why: History of complete heart block with a dualâ€‘chamber pacemaker, coupled with intermittent bradyâ€‘tachyarrhythmia, syncope, hypotension and eventual asystolic arrest suggest a deviceâ€‘related hemodynamic event.
  Supporting features:
    - 12. Complete heart block â€” Diagnosed 6â€¯years ago, treated with pacemaker insertion.
    - 13. Hypertension â€” Patient has a history of hypertension.
    - 53. Electrocardiogram (EMS) â€” Paced rhythm, rate 60â€¯bpm, no ectopy.
    - 54. Electrocardiogram (ED) â€” Pacemaker rate 88â€¯bpm.
    - 68. Syncopal episode (hospital day 1) â€” BP initially 60â€¯mmâ€¯Hg; recovered to 140/68â€¯mmâ€¯Hg after 5â€¯minutes.
    - 71. Outcome â€” On hospital day 8, asystolic cardiac arrest occurred.

6. Infectious pneumonia / lower respiratory tract infection
  Why: Bilateral crackles, new airâ€‘space opacities, hypoxemia, and the administration of broadâ€‘spectrum antibiotics are consistent with a superimposed bacterial pneumonia.
  Supporting features:
    - 51. Lung auscultation â€” Crackles extending halfway up the lungs bilaterally, occasional expiratory wheezes.
    - 55. Chest radiograph (initial) â€” Bilateral coarse reticular opacities, most pronounced at the lung bases.
    - 56. Chest radiograph (subsequent) â€” Bilateral patchy airâ€‘space opacities, indistinct pulmonary vessels, possible small pleural effusions.
    - 38. Ceftriaxone â€” Administered during admission.
    - 39. Azithromycin â€” Administered during admission.
    - 40. Levofloxacin â€” Administered during admission.

7. Thoracic malignancy (lung cancer or mesothelioma)
  Why: Significant smoking history, asbestos exposure, weight loss, lymphadenopathy and pleural plaques raise suspicion for a primary thoracic neoplasm.
  Supporting features:
    - 3. Asbestos exposure â€” Worked in a shipyard with asbestos exposure.
    - 4. Tobacco use â€” Smoked 3 packs per day for 50 years, quit 14 years ago.
    - 22. Weight loss â€” Lost approximately 2.3â€¯kg over the prior 2â€¯months.
    - 57. Chest radiograph (day 2) â€” Calcified pleural plaques on right hemidiaphragm, coarse reticular opacities with increased cystic lucency at both bases.
    - 58. CT chest (day 3) â€” ... lymph nodes 1.5â€‘2.3â€¯cm in diameter; cystic changes, honeycomb, traction bronchiectasis, diffuse asymmetric groundâ€‘glass opacification.

8. Pulmonary embolism
  Why: Acute worsening dyspnea, hypoxemia, rightâ€‘ventricular dilation, hypotension, and syncope are classic features of a massive pulmonary embolus.
  Supporting features:
    - 21. Progressive dyspnea â€” Dyspnea began 6â€¯months prior to admission and progressively worsened.
    - 46. Blood pressure â€” 105/43 mmâ€¯Hg on arrival to the emergency department.
    - 47. Pulse â€” 81 beats per minute on arrival to the emergency department.
    - 48. Respiratory rate â€” 28 breaths per minute on arrival to the emergency department.
    - 49. Oxygen saturation â€” 78â€¯% on room air, 91â€¯% with 6â€¯L/min nasal cannula, 100â€¯% with nonâ€‘rebreather mask.
    - 59. Transthoracic echocardiogram (day 3) â€” Markedly dilated hypokinetic RV; moderateâ€‘toâ€‘severe tricuspidâ€‘valve regurgitation; pulmonary arterial hypertension.

9. Acute respiratory distress syndrome (ARDS) secondary to sepsis or aspiration
  Why: Rapidly progressive hypoxemia refractory to highâ€‘flow oxygen, bilateral diffuse infiltrates, and need for mechanical ventilation are hallmarks of ARDS.
  Supporting features:
    - 49. Oxygen saturation â€” 78â€¯% on room air, 91â€¯% with 6â€¯L/min nasal cannula, 100â€¯% with nonâ€‘rebreather mask; intermittent desaturation to 77â€‘85â€¯% despite highâ€‘flow oxygen.
    - 55. Chest radiograph (initial) â€” Bilateral coarse reticular opacities, most pronounced at the lung bases.
    - 56. Chest radiograph (subsequent) â€” Bilateral patchy airâ€‘space opacities, indistinct pulmonary vessels, possible small pleural effusions.
    - 57. Chest radiograph (day 2) â€” Decreased airâ€‘space opacities, calcified pleural plaques, coarse reticular opacities with increased cystic lucency.
    - 70. Respiratory support escalation â€” Bilevel and CPAP support attempted; eventual intubation and mechanical ventilation on day 7.
    - 38. Ceftriaxone â€” Administered during admission (indicating treatment for possible sepsis).

----- Abduction Phase (Focused) -----
[2026-01-14 16:22:48]
ğŸ§  ABDUCTION (FOCUSED) â€” Diagnostic hypotheses generated:

1. Asbestosis
  Why: Chronic asbestos exposure with pleural plaques and calcifications, progressive dyspnea, weight loss, dry cough, and imaging showing reticular opacities, honeycomb change and traction bronchiectasis consistent with asbestosâ€‘related interstitial fibrosis.
  Supporting features:
    - 3. Asbestos exposure â€” Worked in a shipyard with asbestos exposure.
    - 57. Chest radiograph (day 2) â€” Decreased airâ€‘space opacities, calcified pleural plaques on right hemidiaphragm, coarse reticular opacities with increased cystic lucency at both bases.
    - 58. CT chest (day 3) â€” Calcified pericardium and pleura, diffuse asymmetric groundâ€‘glass opacification, honeycomb changes, traction bronchiectasis.
    - 21. Progressive dyspnea â€” Dyspnea began 6â€¯months prior to admission and progressively worsened.
    - 22. Weight loss â€” Lost approximately 2.3â€¯kg over the prior 2â€¯months.
    - 23. Chronic dry cough â€” Dry cough unchanged throughout the course.
    - 55. Chest radiograph (initial) â€” Bilateral coarse reticular opacities, most pronounced at the lung bases.

2. Idiopathic pulmonary fibrosis (IPF)
  Why: Progressive dyspnea, weight loss, dry cough, and characteristic radiographic findings of basal reticular opacities, honeycombing and traction bronchiectasis without a clear alternative exposure suggest IPF.
  Supporting features:
    - 21. Progressive dyspnea â€” Dyspnea began 6â€¯months prior to admission and progressively worsened.
    - 22. Weight loss â€” Lost approximately 2.3â€¯kg over the prior 2â€¯months.
    - 23. Chronic dry cough â€” Dry cough unchanged throughout the course.
    - 55. Chest radiograph (initial) â€” Bilateral coarse reticular opacities, most pronounced at the lung bases.
    - 58. CT chest (day 3) â€” Diffuse asymmetric groundâ€‘glass opacification, honeycomb changes, traction bronchiectasis.

3. Combined pulmonary fibrosis and emphysema (CPFE)
  Why: Longâ€‘term heavy smoking together with imaging that shows both basal reticular fibrosis/honeycombing and cystic/emphysematous changes is typical of CPFE.
  Supporting features:
    - 4. Tobacco use â€” Smoked 3 packs per day for 50 years, quit 14 years ago.
    - 58. CT chest (day 3) â€” Diffuse asymmetric groundâ€‘glass opacification, honeycomb changes, traction bronchiectasis, cystic changes.
    - 55. Chest radiograph (initial) â€” Bilateral coarse reticular opacities, most pronounced at the lung bases.
    - 57. Chest radiograph (day 2) â€” Increased cystic lucency at both bases.

4. Pulmonary hypertension secondary to interstitial lung disease
  Why: Interstitial lung disease with extensive fibrosis and groundâ€‘glass change, together with echocardiographic evidence of rightâ€‘ventricular dilation, tricuspid regurgitation and elevated pulmonary pressures, explains pulmonary hypertension in this setting.
  Supporting features:
    - 58. CT chest (day 3) â€” Diffuse asymmetric groundâ€‘glass opacification.
    - 59. Transthoracic echocardiogram (day 3) â€” Markedly dilated hypokinetic RV; moderateâ€‘toâ€‘severe tricuspidâ€‘valve regurgitation; pulmonary arterial hypertension.
    - 21. Progressive dyspnea â€” Dyspnea began 6â€¯months prior to admission and progressively worsened.
    - 49. Oxygen saturation â€” 78â€¯% on room air, 91â€¯% with 6â€¯L/min nasal cannula, 100â€¯% with nonâ€‘rebreather mask.

5. Chronic thromboembolic pulmonary hypertension (CTEPH)
  Why: Rightâ€‘ventricular dilation and pulmonary hypertension on echocardiogram, severe hypoxemia, progressive dyspnea and a syncopal episode raise the possibility of chronic thromboembolic disease despite lack of acute clot on CT.
  Supporting features:
    - 59. Transthoracic echocardiogram (day 3) â€” Markedly dilated hypokinetic RV; pulmonary arterial hypertension.
    - 21. Progressive dyspnea â€” Dyspnea began 6â€¯months prior to admission and progressively worsened.
    - 49. Oxygen saturation â€” 78â€¯% on room air, 91â€¯% with 6â€¯L/min nasal cannula, 100â€¯% with nonâ€‘rebreather mask.
    - 68. Syncopal episode (hospital day 1) â€” Blood pressure initially 60â€¯mmâ€¯Hg; recovered to 140/68â€¯mmâ€¯Hg after 5â€¯minutes.

6. Pacemaker leadâ€“induced tricuspid regurgitation causing cor pulmonale
  Why: Dualâ€‘chamber pacemaker leads traversing the tricuspid valve are associated with moderateâ€‘toâ€‘severe regurgitation and RV dilation, explaining rightâ€‘sided failure signs and elevated jugular venous pressure.
  Supporting features:
    - 58. CT chest (day 3) â€” Dualâ€‘chamber pacemaker leads in innominate vein, right atrial appendage, and right ventricular septum.
    - 59. Transthoracic echocardiogram (day 3) â€” Moderateâ€‘toâ€‘severe tricuspidâ€‘valve regurgitation; markedly dilated hypokinetic RV.
    - 50. Jugular venous pressure â€” Visible at 14â€¯cm above the right atrium.
    - 68. Syncopal episode (hospital day 1) â€” Blood pressure initially 60â€¯mmâ€¯Hg; recovered to 140/68â€¯mmâ€¯Hg after 5â€¯minutes.

7. Heart failure with preserved ejection fraction (HFpEF) acute decompensation
  Why: History of hypertension, LV concentric hypertrophy with preserved EF, bilateral crackles, pulmonary edema on imaging, and response to diuretics are consistent with HFpEF exacerbation.
  Supporting features:
    - 13. Hypertension â€” Patient has a history of hypertension.
    - 59. Transthoracic echocardiogram (day 3) â€” Mild concentric LV hypertrophy, EF 54â€¯%.
    - 51. Lung auscultation â€” Crackles extending halfway up the lungs bilaterally, occasional expiratory wheezes.
    - 55. Chest radiograph (initial) â€” Bilateral coarse reticular opacities, most pronounced at the lung bases.
    - 56. Chest radiograph (subsequent) â€” Bilateral patchy airâ€‘space opacities, indistinct pulmonary vessels, possible small pleural effusions.
    - 46. Blood pressure â€” 105/43â€¯mmâ€¯Hg on arrival, later 115/64â€¯mmâ€¯Hg.
    - 62. Intravenous furosemide â€” Administered as 40â€¯mg bolus then 20â€¯mg continuous infusion.

8. Malignant pleural mesothelioma
  Why: Significant asbestos exposure, calcified pleural plaques, pleural calcifications on CT, progressive dyspnea, weight loss, and cough are classic for mesothelioma.
  Supporting features:
    - 3. Asbestos exposure â€” Worked in a shipyard with asbestos exposure.
    - 57. Chest radiograph (day 2) â€” Calcified pleural plaques on right hemidiaphragm.
    - 58. CT chest (day 3) â€” Calcified pericardium and pleura.
    - 22. Weight loss â€” Lost approximately 2.3â€¯kg over the prior 2â€¯months.
    - 21. Progressive dyspnea â€” Dyspnea began 6â€¯months prior to admission and progressively worsened.
    - 23. Chronic dry cough â€” Dry cough unchanged throughout the course.

9. Nonâ€‘small cell lung carcinoma, squamous cell type
  Why: Heavy tobacco use, weight loss, progressive dyspnea, cough, and mediastinal/hilar lymphadenopathy on CT raise suspicion for squamous cell lung cancer.
  Supporting features:
    - 4. Tobacco use â€” Smoked 3 packs per day for 50 years, quit 14 years ago.
    - 22. Weight loss â€” Lost approximately 2.3â€¯kg over the prior 2â€¯months.
    - 21. Progressive dyspnea â€” Dyspnea began 6â€¯months prior to admission and progressively worsened.
    - 23. Chronic dry cough â€” Dry cough unchanged throughout the course.
    - 58. CT chest (day 3) â€” Lymph nodes 1.5â€‘2.3â€¯cm in diameter, diffuse asymmetric groundâ€‘glass opacification.

10. Acute exacerbation of idiopathic pulmonary fibrosis leading to ARDS
  Why: Rapid worsening of dyspnea, refractory hypoxemia despite highâ€‘flow oxygen, new bilateral airâ€‘space opacities on chest radiographs, and diffuse groundâ€‘glass change on CT are compatible with an IPF acute exacerbation meeting ARDS criteria.
  Supporting features:
    - 21. Progressive dyspnea â€” Dyspnea began 6â€¯months prior to admission and progressively worsened.
    - 49. Oxygen saturation â€” 78â€¯% on room air, 91â€¯% with 6â€¯L/min nasal cannula, 100â€¯% with nonâ€‘rebreather mask; intermittent desaturation to 77â€‘85â€¯% despite highâ€‘flow oxygen.
    - 55. Chest radiograph (initial) â€” Bilateral coarse reticular opacities, most pronounced at the lung bases.
    - 56. Chest radiograph (subsequent) â€” Bilateral patchy airâ€‘space opacities, indistinct pulmonary vessels, possible small pleural effusions.
    - 58. CT chest (day 3) â€” Diffuse asymmetric groundâ€‘glass opacification.
    - 70. Respiratory support escalation â€” Bilevel and CPAP support attempted; eventual intubation and mechanical ventilation on day 7.

----- Ranking Phase -----
[2026-01-14 16:24:00]
ğŸ RANKING â€” Hypotheses ordered by plausibility:

#1 â€” Asbestosis
  Parsimony: .
  Danger: .
  Cost: .
  Curability: .

#2 â€” Acute exacerbation of idiopathic pulmonary fibrosis leading to ARDS
  Parsimony: .
  Danger: .
  Cost: .
  Curability: .

#3 â€” Idiopathic pulmonary fibrosis (IPF)
  Parsimony: .
  Danger: .
  Cost: .
  Curability: .

#4 â€” Combined pulmonary fibrosis and emphysema (CPFE)
  Parsimony: .
  Danger: .
  Cost: .
  Curability: .

#5 â€” Pacemaker leadâ€“induced tricuspid regurgitation causing cor pulmonale
  Parsimony: .
  Danger: .
  Cost: .
  Curability: .

#6 â€” Pulmonary hypertension secondary to interstitial lung disease
  Parsimony: .
  Danger: .
  Cost: .
  Curability: .

#7 â€” Heart failure with preserved ejection fraction (HFpEF) acute decompensation
  Parsimony: .
  Danger: .
  Cost: .
  Curability: .

#8 â€” Chronic thromboembolic pulmonary hypertension (CTEPH)
  Parsimony: .
  Danger: .
  Cost: .
  Curability: .

#9 â€” Malignant pleural mesothelioma
  Parsimony: .
  Danger: .
  Cost: .
  Curability: .

#10 â€” Nonâ€‘small cell lung carcinoma, squamous cell type
  Parsimony: .
  Danger: .
  Cost: .
  Curability: .

----- Deduction Phase -----
[2026-01-14 16:25:42]
ğŸ”® DEDUCTION â€” Expected consequences per hypothesis:

â€¢ Asbestosis
  - [ğŸ”´ HIGH | â³ clinical_course] Diffuse lowerâ€‘zone reticular opacities on highâ€‘resolution CT (HRCT) with subpleural curvilinear lines.
  - [ğŸ”´ HIGH | â³ clinical_course] Calcified pleural plaques, especially diaphragmatic, on chest CT.
  - [ğŸ”´ HIGH | â³ clinical_course] History of occupational asbestos exposure (shipbuilding, insulation, roofing).
  - [ğŸŸ  MED | â³ clinical_course] Reduced diffusing capacity for carbon monoxide (DLCO) disproportionate to spirometric restriction.
  - [ğŸŸ¢ LOW | â³ clinical_course] Absence of extensive honeycombing typical of idiopathic pulmonary fibrosis.

â€¢ Acute exacerbation of idiopathic pulmonary fibrosis leading to ARDS
  - [ğŸ”´ HIGH | â³ clinical_course] Rapid worsening of dyspnea over days with new hypoxemia refractory to oxygen.
  - [ğŸ”´ HIGH | â³ clinical_course] New groundâ€‘glass opacities superimposed on chronic fibrosis on HRCT.
  - [ğŸ”´ HIGH | â³ clinical_course] Limited response to highâ€‘dose corticosteroids; high shortâ€‘term mortality.
  - [ğŸŸ  MED | â³ clinical_course] Elevated inflammatory markers (CRP, ESR) without infectious source.
  - [ğŸŸ  MED | â³ clinical_course] BAL fluid with neutrophilic predominance, negative cultures.

â€¢ Idiopathic pulmonary fibrosis (IPF)
  - [ğŸ”´ HIGH | â³ clinical_course] Progressive exertional dyspnea and dry cough over months to years.
  - [ğŸ”´ HIGH | â³ clinical_course] Usual interstitial pneumonia (UIP) pattern on HRCT: basal honeycombing, reticulation, traction bronchiectasis.
  - [ğŸ”´ HIGH | â³ clinical_course] Reduced DLCO and restrictive spirometry (â†“FVC, normal/high FEV1/FVC).
  - [ğŸŸ  MED | â³ clinical_course] Digital clubbing in a subset of patients.
  - [ğŸŸ  MED | â³ clinical_course] No identifiable environmental or occupational exposure.

â€¢ Combined pulmonary fibrosis and emphysema (CPFE)
  - [ğŸ”´ HIGH | â³ clinical_course] Upperâ€‘lobe emphysema with lowerâ€‘lobe fibrosis on HRCT.
  - [ğŸ”´ HIGH | â³ clinical_course] Preserved lung volumes (nearâ€‘normal FVC) but markedly reduced DLCO.
  - [ğŸ”´ HIGH | â³ clinical_course] Heavy smoking history (â‰¥30 packâ€‘years).
  - [ğŸŸ  MED | â³ clinical_course] Higher prevalence of pulmonary hypertension (elevated PASP on echo).
  - [ğŸŸ¢ LOW | â³ clinical_course] Absence of significant chronic bronchitis symptoms.

â€¢ Pacemaker leadâ€“induced tricuspid regurgitation causing cor pulmonale
  - [ğŸ”´ HIGH | â³ clinical_course] New or worsening rightâ€‘sided heart failure signs: peripheral edema, jugular venous distension, hepatomegaly.
  - [ğŸ”´ HIGH | â³ clinical_course] Tricuspid regurgitation murmur with holosystolic component on auscultation.
  - [ğŸ”´ HIGH | â³ clinical_course] Echocardiography showing pacemaker lead traversing the tricuspid valve with leaflet tethering and regurgitation.
  - [ğŸŸ  MED | â³ clinical_course] Elevated right atrial pressure and right ventricular dilation on echo.
  - [ğŸŸ¢ LOW | â³ clinical_course] Normal pulmonary parenchyma on chest imaging; absence of interstitial disease.

â€¢ Pulmonary hypertension secondary to interstitial lung disease
  - [ğŸ”´ HIGH | â³ clinical_course] Elevated pulmonary artery systolic pressure (PASP >35â€¯mmHg) on transthoracic echocardiography.
  - [ğŸ”´ HIGH | â³ clinical_course] Right ventricular hypertrophy and/or dilation on echo or MRI.
  - [ğŸŸ  MED | â³ clinical_course] Reduced DLCO disproportionate to spirometric restriction.
  - [ğŸŸ  MED | â³ clinical_course] Exertional dyspnea out of proportion to fibrosis extent; possible syncope.
  - [ğŸŸ¢ LOW | â³ clinical_course] Normal pulmonary capillary wedge pressure (<15â€¯mmHg) on rightâ€‘heart catheterization.

â€¢ Heart failure with preserved ejection fraction (HFpEF) acute decompensation
  - [ğŸ”´ HIGH | â³ clinical_course] Elevated natriuretic peptides (BNP or NTâ€‘proBNP) above ageâ€‘adjusted thresholds.
  - [ğŸ”´ HIGH | â³ clinical_course] Chest Xâ€‘ray showing pulmonary vascular congestion and interstitial edema without cardiomegaly.
  - [ğŸ”´ HIGH | â³ clinical_course] Echocardiography demonstrating preserved left ventricular ejection fraction (â‰¥50â€¯%) with evidence of diastolic dysfunction (elevated E/eâ€²).
  - [ğŸŸ  MED | â³ clinical_course] Peripheral edema, orthopnea, and rapid weight gain.
  - [ğŸŸ  MED | â³ clinical_course] Marked improvement with intravenous diuretics and fluid restriction.

â€¢ Chronic thromboembolic pulmonary hypertension (CTEPH)
  - [ğŸ”´ HIGH | â³ clinical_course] Ventilationâ€‘perfusion (V/Q) scan showing multiple mismatched perfusion defects.
  - [ğŸ”´ HIGH | â³ clinical_course] CT pulmonary angiography revealing webs, bands, or chronic thrombus within segmental arteries.
  - [ğŸ”´ HIGH | â³ clinical_course] Elevated PASP on echocardiography with rightâ€‘heart enlargement.
  - [ğŸŸ  MED | â³ clinical_course] History of prior acute pulmonary embolism or risk factors for thrombosis.
  - [ğŸŸ¢ LOW | â³ clinical_course] Normal lung parenchyma on CT (absence of fibrosis or emphysema).

â€¢ Malignant pleural mesothelioma
  - [ğŸ”´ HIGH | â³ clinical_course] Diffuse pleural thickening with nodular involvement on chest CT, often encasing the lung.
  - [ğŸ”´ HIGH | â³ clinical_course] Unilateral or bilateral pleural effusion, often hemorrhagic.
  - [ğŸ”´ HIGH | â³ clinical_course] History of significant asbestos exposure (occupational or environmental).
  - [ğŸŸ  MED | â³ clinical_course] Elevated serum mesothelinâ€‘related peptide (SMRP) or osteopontin.
  - [ğŸŸ¢ LOW | â³ clinical_course] Weight loss, fatigue, and chest wall pain.

â€¢ Nonâ€‘small cell lung carcinoma, squamous cell type
  - [ğŸ”´ HIGH | â³ clinical_course] Central cavitary lung mass on chest CT, often adjacent to major bronchi.
  - [ğŸ”´ HIGH | â³ clinical_course] History of heavy smoking (â‰¥30 packâ€‘years).
  - [ğŸ”´ HIGH | â³ clinical_course] FDGâ€‘avid lesion on PETâ€‘CT with possible mediastinal nodal involvement.
  - [ğŸŸ  MED | â³ clinical_course] Hemoptysis or recurrent bronchitis due to airway obstruction.
  - [ğŸŸ  MED | â³ clinical_course] Elevated serum SCC antigen.

----- Induction Phase -----
[2026-01-14 16:28:30]
ğŸ§¾ INDUCTION â€” Matching expected vs observed:

â€¢ Asbestosis
  Evaluation: plausible
  Termination: continue_testing
  Why: continue_testing
  Findings summary: âœ… 2 | â“ 2 | âŒ 1
  Findings:
    - â“ Diffuse lowerâ€‘zone reticular opacities on highâ€‘resolution CT (HRCT) with subpleural curvilinear lines.
      â†³ 
    - âœ… Calcified pleural plaques, especially diaphragmatic, on chest CT.
      â†³ 
    - â“ Reduced diffusing capacity for carbon monoxide (DLCO) disproportionate to spirometric restriction.
      â†³ 
    - âœ… History of occupational asbestos exposure (shipbuilding, insulation, roofing).
      â†³ 
    - âŒ Absence of extensive honeycombing typical of idiopathic pulmonary fibrosis.
      â†³ 

â€¢ Acute exacerbation of idiopathic pulmonary fibrosis leading to ARDS
  Evaluation: plausible
  Termination: continue_testing
  Why: continue_testing
  Findings summary: âœ… 3 | â“ 2 | âŒ 0
  Findings:
    - âœ… Rapid worsening of dyspnea over days with new hypoxemia refractory to oxygen.
      â†³ 
    - âœ… New groundâ€‘glass opacities superimposed on chronic fibrosis on HRCT.
      â†³ 
    - â“ Elevated inflammatory markers (CRP, ESR) without infectious source.
      â†³ 
    - â“ BAL fluid with neutrophilic predominance, negative cultures.
      â†³ 
    - âœ… Limited response to highâ€‘dose corticosteroids; high shortâ€‘term mortality.
      â†³ 

â€¢ Idiopathic pulmonary fibrosis (IPF)
  Evaluation: refuted
  Termination: reopen_abduction
  Why: reopen_abduction
  Findings summary: âœ… 2 | â“ 2 | âŒ 1
  Findings:
    - âœ… Progressive exertional dyspnea and dry cough over months to years.
      â†³ 
    - âœ… Usual interstitial pneumonia (UIP) pattern on HRCT: basal honeycombing, reticulation, traction bronchiectasis.
      â†³ 
    - â“ Reduced DLCO and restrictive spirometry (â†“FVC, normal/high FEV1/FVC).
      â†³ 
    - â“ Digital clubbing in a subset of patients.
      â†³ 
    - âŒ No identifiable environmental or occupational exposure.
      â†³ 

â€¢ Combined pulmonary fibrosis and emphysema (CPFE)
  Evaluation: plausible
  Termination: continue_testing
  Why: continue_testing
  Findings summary: âœ… 2 | â“ 3 | âŒ 0
  Findings:
    - â“ Upperâ€‘lobe emphysema with lowerâ€‘lobe fibrosis on HRCT.
      â†³ 
    - â“ Preserved lung volumes (nearâ€‘normal FVC) but markedly reduced DLCO.
      â†³ 
    - âœ… Heavy smoking history (â‰¥30 packâ€‘years).
      â†³ 
    - âœ… Higher prevalence of pulmonary hypertension (elevated PASP on echo).
      â†³ 
    - â“ Absence of significant chronic bronchitis symptoms.
      â†³ 

â€¢ Pacemaker leadâ€“induced tricuspid regurgitation causing cor pulmonale
  Evaluation: refuted
  Termination: reopen_abduction
  Why: reopen_abduction
  Findings summary: âœ… 2 | â“ 2 | âŒ 1
  Findings:
    - âœ… New or worsening rightâ€‘sided heart failure signs: peripheral edema, jugular venous distension, hepatomegaly.
      â†³ 
    - â“ Tricuspid regurgitation murmur with holosystolic component on auscultation.
      â†³ 
    - â“ Echocardiography showing pacemaker lead traversing the tricuspid valve with leaflet tethering and regurgitation.
      â†³ 
    - âœ… Elevated right atrial pressure and right ventricular dilation on echo.
      â†³ 
    - âŒ Normal pulmonary parenchyma on chest imaging; absence of interstitial disease.
      â†³ 

â€¢ Pulmonary hypertension secondary to interstitial lung disease
  Evaluation: plausible
  Termination: continue_testing
  Why: continue_testing
  Findings summary: âœ… 3 | â“ 2 | âŒ 0
  Findings:
    - âœ… Elevated pulmonary artery systolic pressure (PASP >35â€¯mmHg) on transthoracic echocardiography.
      â†³ 
    - âœ… Right ventricular hypertrophy and/or dilation on echo or MRI.
      â†³ 
    - â“ Reduced DLCO disproportionate to spirometric restriction.
      â†³ 
    - âœ… Exertional dyspnea out of proportion to fibrosis extent; possible syncope.
      â†³ 
    - â“ Normal PCWP on right heart catheterization.
      â†³ 

â€¢ Heart failure with preserved ejection fraction (HFpEF) acute decompensation
  Evaluation: refuted
  Termination: reopen_abduction
  Why: reopen_abduction
  Findings summary: âœ… 1 | â“ 3 | âŒ 1
  Findings:
    - â“ Elevated natriuretic peptides (BNP, NTâ€‘proBNP).
      â†³ 
    - â“ Chest Xâ€‘ray showing pulmonary vascular congestion and interstitial edema without cardiomegaly.
      â†³ 
    - âœ… Echocardiography demonstrating preserved LVEF with diastolic dysfunction.
      â†³ 
    - â“ Peripheral edema, orthopnea, rapid weight gain.
      â†³ 
    - âŒ Marked improvement with highâ€‘dose intravenous diuretics.
      â†³ 

â€¢ Chronic thromboembolic pulmonary hypertension (CTEPH)
  Evaluation: refuted
  Termination: reopen_abduction
  Why: reopen_abduction
  Findings summary: âœ… 1 | â“ 3 | âŒ 1
  Findings:
    - â“ Ventilationâ€‘perfusion (V/Q) scan showing mismatched perfusion defects.
      â†³ 
    - â“ CT angiography showing chronic thrombus.
      â†³ 
    - âœ… Elevated PASP on echo.
      â†³ 
    - â“ History of prior pulmonary embolism or risk factors.
      â†³ 
    - âŒ Normal lung parenchyma on CT.
      â†³ 

â€¢ Malignant pleural mesothelioma
  Evaluation: refuted
  Termination: reopen_abduction
  Why: reopen_abduction
  Findings summary: âœ… 3 | â“ 2 | âŒ 0
  Findings:
    - â“ Diffuse pleural thickening with nodular involvement, encasing lung.
      â†³ 
    - âœ… Pleural effusion, often hemorrhagic.
      â†³ 
    - âœ… Asbestos exposure.
      â†³ 
    - â“ Elevated serum mesothelin (mesothelinâ€‘related peptides).
      â†³ 
    - âœ… Weight loss, fatigue, chest pain.
      â†³ 

â€¢ Nonâ€‘small cell lung carcinoma, squamous cell type
  Evaluation: refuted
  Termination: reopen_abduction
  Why: reopen_abduction
  Findings summary: âœ… 1 | â“ 4 | âŒ 0
  Findings:
    - â“ Central cavitary lung mass on chest CT.
      â†³ 
    - âœ… Heavy smoking history (â‰¥30 packâ€‘years).
      â†³ 
    - â“ Hemoptysis or recurrent bronchitis.
      â†³ 
    - â“ Elevated serum SCC antigen.
      â†³ 
    - â“ FDGâ€‘avid lesion on PETâ€‘CT.
      â†³ 

----- Ranking Phase -----
[2026-01-14 16:29:47]
ğŸ RANKING â€” Hypotheses ordered by plausibility:

#1 â€” Acute exacerbation of idiopathic pulmonary fibrosis leading to ARDS
  Parsimony: Requires the additional premise of an underlying IPF, making it less parsimonious than a single fibrotic process, but the acute ARDS component explains the rapid decompensation.
  Danger: Highest immediate danger; ARDS carries >50â€¯% shortâ€‘term mortality and mandates emergent ICU care.
  Cost: High â€“ needs bronchoscopy, BAL, highâ€‘dose steroids, mechanical ventilation, and intensive monitoring.
  Curability: Very low; acute exacerbations are usually fatal despite maximal therapy.

#2 â€” Asbestosis
  Parsimony: A single occupational exposure accounts for the chronic interstitial changes, pleural plaques, and progressive dyspnea.
  Danger: Moderate; disease progresses slowly but can precipitate severe hypoxemia and rightâ€‘heart failure.
  Cost: Moderate â€“ chest CT, pulmonary function testing, and occasional biopsy are sufficient.
  Curability: None; treatment is supportive, but disease progression can be slowed.

#3 â€” Pulmonary hypertension secondary to interstitial lung disease
  Parsimony: Adds only a hemodynamic consequence to the existing interstitial process, keeping the explanatory model simple.
  Danger: High; rightâ€‘ventricular failure can be rapidly fatal, especially when PH is severe.
  Cost: Moderate â€“ echocardiography, rightâ€‘heart catheterisation if needed, and basic labs.
  Curability: Limited; PH can be partially managed but underlying fibrosis remains incurable.

#4 â€” Combined pulmonary fibrosis and emphysema (CPFE)
  Parsimony: Requires two coâ€‘existing pathologies (upperâ€‘lobe emphysema and lowerâ€‘lobe fibrosis), making it less simple than a single disease.
  Danger: Moderate to high; CPFE is associated with severe PH and rapid functional decline.
  Cost: Moderate â€“ highâ€‘resolution CT to delineate emphysema and fibrosis, pulmonary function tests.
  Curability: None; both components are irreversible, management is supportive.

#5 â€” Idiopathic pulmonary fibrosis (IPF)
  Parsimony: A single idiopathic fibrotic process explains the imaging findings, but the known asbestos exposure makes a secondary cause more parsimonious.
  Danger: High; IPF has a median survival of 3â€‘5â€¯years and can acutely worsen.
  Cost: Moderate â€“ HRCT, PFTs, possibly lung biopsy.
  Curability: None; antifibrotic therapy may slow progression but cure is unavailable.

#6 â€” Pacemaker leadâ€“induced tricuspid regurgitation causing cor pulmonale
  Parsimony: Adds a mechanical valve lesion to explain rightâ€‘heart failure, but imaging shows extensive interstitial disease, making this less simple.
  Danger: Low to moderate; tricuspid regurgitation contributes to RV overload but is not the primary driver of the acute hypoxemia.
  Cost: Low â€“ echocardiography and lead imaging are inexpensive.
  Curability: Potentially correctable by lead revision, but patientâ€™s overall prognosis remains poor due to lung disease.

#7 â€” Heart failure with preserved ejection fraction (HFpEF) acute decompensation
  Parsimony: Explains dyspnea with preserved systolic function, yet fails to account for extensive interstitial changes and lack of volume overload.
  Danger: Moderate; HFpEF can cause pulmonary congestion but the patientâ€™s refractory hypoxemia points to a pulmonary primary.
  Cost: Low â€“ BNP, echo, diuretic trial.
  Curability: Manageable with diuretics and bloodâ€‘pressure control, but does not address underlying fibrosis.

#8 â€” Chronic thromboembolic pulmonary hypertension (CTEPH)
  Parsimony: Adds chronic thrombus to explain PH, yet CT shows normal parenchyma and no evidence of thrombus, making it less parsimonious.
  Danger: High if present, but current data do not support it.
  Cost: High â€“ V/Q scan, CTâ€‘angiography, rightâ€‘heart catheterisation.
  Curability: Potentially curable with pulmonary endarterectomy, but unlikely in this case.

#9 â€” Malignant pleural mesothelioma
  Parsimony: Requires a malignant pleural process in addition to fibrosis; imaging lacks diffuse pleural thickening or effusion, reducing simplicity.
  Danger: Very high if present, but absent radiographic hallmarks lower immediate concern.
  Cost: High â€“ PETâ€‘CT, biopsy, pleural fluid analysis.
  Curability: Poor; limited to palliative measures.

#10 â€” Nonâ€‘small cell lung carcinoma, squamous cell type
  Parsimony: Adds a solitary tumor to a picture dominated by diffuse interstitial disease, making it the least parsimonious.
  Danger: High if present, yet no mass or hemoptysis is observed.
  Cost: High â€“ contrast CT, bronchoscopy, PETâ€‘CT, biopsy.
  Curability: Potentially curable if early, but unlikely given lack of evidence.
